1. Quality of life in patients with advanced epithelial ovarian cancer (EOC) randomized to maintenance pazopanib or placebo after first-line chemotherapy in the AGO-OVAR 16 trial. Measuring what matters—patient-centered end points in trials of maintenance therapy. (18th December 2017) Authors: Friedlander, M; Rau, J; Lee, C K; Meier, W; Lesoin, A; Kim, J -W; Poveda, A; Buck, M; Scambia, G; Shimada, M; Hilpert, F; King, M T; Debruyne, P; Bologna, A; Malander, S; Monk, B J; Petru, E; Calvert, P; Herzog, T J; Barrett, C Journal: Annals of oncology Issue: Volume 29:Number 3(2018) Page Start: 737 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. LBA10Phase III PAOLA-1/ENGOT-ov25 trial: Olaparib plus bevacizumab (bev) as maintenance therapy in patients (pts) with newly diagnosed, advanced ovarian cancer (OC) treated with platinum-based chemotherapy (PCh) plus bev. (24th November 2019) Authors: Fujiwara, K; Harter, P; Leary, A; Perol, D; Pignata, S; González-Martín, A; Petru, E; van Nieuwenhuysen, E; Colombo, N; Mäenpää, J; Selle, F; de Gregorio, N; Lorusso, D; Guerra Alia, E M; Lefeuvre-Plesse, C; Buderath, P; Lortholary, A; Burges, A; Pujade-Lauraine, E; Ray-Coquard, I L Journal: Annals of oncology Issue: Volume 30(2019)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Long-term disease-free survival after breast cancer metastatic to the ovary. Issue 3 (1st April 2002) Authors: Zehetleitner, G; Thiel, I; Petru, E Journal: International journal of gynecological cancer Issue: Volume 12:Issue 3(2002) Page Start: 317 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗